Loading stock…

Molina Healthcare, Inc. (MOH) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Molina Healthcare, Inc.

MOHMarket cap $10BPrice $195.8

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Manages Medicaid, Medicare, and Marketplace health plans for low-income and government-sponsored patients across the US. Covers over 5 million members, betting on government contracts rather than employer-based insurance to drive growth.

In Bastion Portfolios?

52W Return+2%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+12%7

Revenue Forecast

Rev CAGR (1y)+2%3

Rev CAGR (3y)+6%4

Rev CAGR (5y)+5%4

Earnings Forecast

EPS Growth Y+1-42%2

EPS Growth Y+2+92%10

EPS Growth Y+3+36%9

Quality

Margins

EBIT Margin1%2

Net Income Margin-0%2

Free Cash Flow Margin1%3

Debt

Net Debt/EBITDA-2.610

Efficiency

ROE-0%2

ROA-0%2

Earnings Stability77

GEAR+WEAK21

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)272

P/E Ratio (Forward 3y)155

P/BV2.46

EV Multiples

EV/EBITDA Fwd135

EV/EBIT Fwd165

Yield

Free Cash Flow Yield2.7%4

Dividend Yieldna–

Momentum

Short term

1 month return+1%8

3 month return-16%2

YTD return+13%7

Mid term

Price vs 52wHigh80%5

1 year return-2%4

Long term

3 year return-42%1

5 year return-30%2

Risk Shield

Price Risk

Beta-0.210

Volatility56%2

Free Cash Flow

Free Cash Flow Margin1%3

Free Cash Flow Yield2.7%4

Quality

ROCE4%3

Earnings Stability77

Net Debt/EBITDA-2.610

02Growth

Is it actually growing, and how fast?

MOHMolina Healthcare

Revenue FY25$45.4B

GROWTH RATING↗

AVERAGE38 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+12%7

Revenue, next 1Y+2%3

Revenue, next 3Y, CAGR+6%4

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-42%2

EPS growth, FY27E+92%10

EPS growth, FY28E+36%9

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 12%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

A mid-pack grower, ahead of 38% of companies worldwide.

Revenue is set to grow 6%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 12%/yr over the last 3 years; forecasts see it cooling to 6%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK20 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+1%8

3-month return-16%2

YTD return+13%7

MID & LONG-TERM▾SCORE

% of 52-week high80%5

1-year return-2%4

3-year return-42%1

5-year return-30%2

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+1%) and so far this year (+13%).

WATCH

It's down 2% over the past year, now 20% below its 52-week high. That is right in line with the market.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-42% over three years and -30% over five), behind 80% of the market.

The stock is underperforming over three months (-16%).

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Molina. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

MOHMolina Healthcare

Revenue FY25$45.4B

GROWTH RATING↗

AVERAGE38 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+12%7

Revenue, next 1Y+2%3

Revenue, next 3Y, CAGR+6%4

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E-42%2

EPS growth, FY27E+92%10

EPS growth, FY28E+36%9

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 12%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

WATCH

A mid-pack grower, ahead of 38% of companies worldwide.

Revenue is set to grow 6%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 12%/yr over the last 3 years; forecasts see it cooling to 6%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK20 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+1%8

3-month return-16%2

YTD return+13%7

MID & LONG-TERM▾SCORE

% of 52-week high80%5

1-year return-2%4

3-year return-42%1

5-year return-30%2

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+1%) and so far this year (+13%).

WATCH

It's down 2% over the past year, now 20% below its 52-week high. That is right in line with the market.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-42% over three years and -30% over five), behind 80% of the market.

The stock is underperforming over three months (-16%).

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Molina. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community